Terry Day to Neoplasm Recurrence, Local
This is a "connection" page, showing publications Terry Day has written about Neoplasm Recurrence, Local.
Connection Strength
1.313
-
Benign Parotid Tumors. Otolaryngol Clin North Am. 2016 Apr; 49(2):327-42.
Score: 0.421
-
Endocrine mucin-producing sweat gland carcinoma: a systematic review and meta-analysis. J Dermatolog Treat. 2022 Jun; 33(4):2182-2191.
Score: 0.159
-
Immune Checkpoint Inhibitors for Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-Analysis. Target Oncol. 2021 11; 16(6):743-752.
Score: 0.155
-
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
Score: 0.155
-
Hypermetabolic Vocal Cord Focus With Recurrent Oral Cancer History. JAMA Oncol. 2018 Feb 01; 4(2):248-249.
Score: 0.120
-
PET/CT in the assessment of previously treated skull base malignancies. Head Neck. 2010 Jan; 32(1):76-84.
Score: 0.068
-
Cranial neuropathy as a presenting sign of recurrent aggressive skin cancer. Dermatol Surg. 2008 Apr; 34(4):483-97.
Score: 0.060
-
Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users. Arch Otolaryngol Head Neck Surg. 2007 Jan; 133(1):28-31.
Score: 0.055
-
Systematic review of neuroendocrine carcinomas of the oropharynx. Head Neck. 2022 07; 44(7):1725-1736.
Score: 0.040
-
Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma. Hum Immunol. 2010 Jul; 71(7):659-65.
Score: 0.018
-
Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers. Head Neck. 2009 Apr; 31(4):493-502.
Score: 0.016
-
Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys. 2009 Apr 01; 73(5):1313-8.
Score: 0.016
-
Effect of body mass index on chemoradiation outcomes in head and neck cancer. Laryngoscope. 2008 Jul; 118(7):1180-5.
Score: 0.015
-
Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis. Cancer Lett. 2007 Oct 18; 256(1):101-11.
Score: 0.014